European Commission Approves Label Extension of Cystic Fibrosis Drug
AdinaVoicu / Pixabay

European Commission Approves Label Extension of Cystic Fibrosis Drug

According to a story from BioPortfolio, the biotechnology company Vertex Pharmaceuticals recently announced that the European Commission has approved a label extension for the company's cystic fibrosis drug Orkambi. Under…

Continue Reading European Commission Approves Label Extension of Cystic Fibrosis Drug
Recent Research Links Hereditary Hemochromatosis to Joint Diseases and Cancers
stevepb / Pixabay

Recent Research Links Hereditary Hemochromatosis to Joint Diseases and Cancers

According to a story from news-medical.net, a recent study has a found that a hidden disease called hemochromatosis could be a major risk factor for several different joint diseases and…

Continue Reading Recent Research Links Hereditary Hemochromatosis to Joint Diseases and Cancers
Pharnext Announces Preclinical Trial Results Affecting Onset of Charcot-Marie-Tooth Disease 1A
source: pixabay.com

Pharnext Announces Preclinical Trial Results Affecting Onset of Charcot-Marie-Tooth Disease 1A

Pharnext SA, a biopharmaceutical company, recently announced results in a PLOS ONE article entitled "Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A…

Continue Reading Pharnext Announces Preclinical Trial Results Affecting Onset of Charcot-Marie-Tooth Disease 1A